13393274 · Active · incorporated 5 years, 3 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Apollo Therapeutics is a biopharmaceutical company focused on developing novel therapeutics for various diseases, often through licensing and collaboration.
Apollo Therapeutics is a private limited company registered at Companies House under number 13393274, incorporated on 13 May 2021, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is activities of other holding companies n.e.c. (SIC 64209). Sonde has indexed 67 filings for this company, including 2 funding rounds. Its most recent round closed in December 2023, raising £207.3m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Dec 2023 | £207.3m | £1.49 |
| Round 1 | Jun 2021 | £145.2m | £1.00 |
Showing the 10 most recent of 67 filings.
See the complete cap table with every shareholder, founder tags, dilution across 19 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.